Quantitative EEG in Corticobasal Syndrome
Overview
flowchart TD
diagnostics_qeeg_cortico_basal["qeeg-cortico-basal-syndrome"]
style diagnostics_qeeg_cortico_basal fill:#4fc3f7,stroke:#333,color:#000
diagnostics_qeeg_cor_0["qEEG Methodology"]
diagnostics_qeeg_cortico_basal -->|"includes"| diagnostics_qeeg_cor_0
style diagnostics_qeeg_cor_0 fill:#81c784,stroke:#333,color:#000
diagnostics_qeeg_cor_1["Recording Parameters"]
diagnostics_qeeg_cortico_basal -->|"includes"| diagnostics_qeeg_cor_1
style diagnostics_qeeg_cor_1 fill:#ef5350,stroke:#333,color:#000
diagnostics_qeeg_cor_2["Quantitative Measures"]
diagnostics_qeeg_cortico_basal -->|"includes"| diagnostics_qeeg_cor_2
style diagnostics_qeeg_cor_2 fill:#ffd54f,stroke:#333,color:#000
diagnostics_qeeg_cor_3["CBS-Specific qEEG Findings"]
diagnostics_qeeg_cortico_basal -->|"includes"| diagnostics_qeeg_cor_3
style diagnostics_qeeg_cor_3 fill:#ce93d8,stroke:#333,color:#000
diagnostics_qeeg_cor_4["Asymmetric Background Slowing"]
diagnostics_qeeg_cortico_basal -->|"includes"| diagnostics_qeeg_cor_4
style diagnostics_qeeg_cor_4 fill:#4fc3f7,stroke:#333,color:#000
diagnostics_qeeg_cor_5["Increased Theta Power"]
diagnostics_qeeg_cortico_basal -->|"includes"| diagnostics_qeeg_cor_5
style diagnostics_qeeg_cor_5 fill:#81c784,stroke:#333,color:#000
...Quantitative EEG in Corticobasal Syndrome
Overview
Mermaid diagram (expand to render)
Quantitative electroencephalography (qEEG) has emerged as a valuable non-invasive biomarker for the diagnosis and characterization of [corticobasal syndrome (CBS)](/diseases/corticobasal-syndrome). Unlike standard visual EEG analysis, qEEG applies mathematical algorithms to quantify spectral power, frequency distribution, coherence, and connectivity patterns across brain regions. In CBS, qEEG reveals characteristic abnormalities that reflect the underlying cortical degeneration and can aid in differential diagnosis from [progressive supranuclear palsy (PSP)](/diseases/progressive-supranuclear-palsy) and [Parkinson's disease (PD)](/diseases/parkinsons-disease) [@martinez2023][@ghosh2024].
The key qEEG findings in CBS include asymmetric background slowing, increased theta power, reduced alpha/theta ratio, and disrupted interhemispheric coherence. These abnormalities correlate with clinical features including cognitive impairment, apraxia severity, and disease progression [@schmitt2022][@kojovic2024].
qEEG Methodology
Recording Parameters
Standard qEEG recordings for CBS assessment follow the International 10-20 system with 19-21 scalp electrodes. Key parameters include:
| Parameter | Standard Protocol |
|-----------|-------------------|
| Recording duration | 20-30 minutes (awake, eyes closed) |
| Sampling rate | 256-512 Hz |
| Frequency bands | Delta (0.5-4 Hz), Theta (4-8 Hz), Alpha (8-13 Hz), Beta (13-30 Hz), Gamma (>30 Hz) |
| Reference | Average reference or linked mastoid |
| Artifact rejection | Manual inspection for ocular, muscular, and movement artifacts |
Quantitative Measures
The primary qEEG measures assessed in CBS include:
- Spectral power: Absolute and relative power in each frequency band
- Alpha/theta ratio: Ratio of alpha power to theta power (indicator of cortical function)
- Asymmetry index: Interhemispheric differences in spectral power
- Coherence: Inter-electrode correlation in specific frequency bands
- Dominant frequency: Peak frequency of the background rhythm
CBS-Specific qEEG Findings
Asymmetric Background Slowing
One of the hallmark qEEG findings in [corticobasal syndrome](/diseases/corticobasal-syndrome) is asymmetric background slowing, reflecting the focal cortical pathology that characterizes the disease [@onofrio2023]. Unlike [PSP](/diseases/progressive-supranuclear-palsy), which typically shows symmetric abnormalities, CBS demonstrates:
- Lateralized theta/delta power increase over the more affected hemisphere
- Alpha rhythm slowing that is more pronounced contralateral to the clinically affected side
- Asymmetry indices significantly higher in CBS compared to PSP and PD
The asymmetry in CBS correlates with:
- The side of predominant motor symptoms (rigidity, apraxia)
- The distribution of cortical atrophy on [MRI](/diagnostics/mri-findings-in-corticobasal-syndrome)
- The severity of ideomotor apraxia
Increased Theta Power
Generalized theta power increase is a consistent finding in CBS [@ghosh2024][@benninger2021]:
- Frontal theta predominance: Theta activity is typically most prominent over frontal regions, reflecting frontal cortical involvement
- Correlation with disease severity: Higher theta power correlates with more severe motor and cognitive impairment
- Progressive increase: Theta power tends to increase with disease progression
| Disease Stage | Theta Power Pattern |
|---------------|---------------------|
| Early CBS | Mild frontal theta increase |
| Moderate CBS | Prominent generalized theta |
| Advanced CBS | Diffuse theta-delta slowing |
Reduced Alpha/Theta Ratio
The alpha/theta ratio serves as a sensitive biomarker for cortical dysfunction in CBS [@schmitt2022]:
- Significantly reduced compared to healthy controls and PD patients
- Lower values correlate with cognitive impairment: Patients with lower alpha/theta ratios demonstrate more severe cognitive deficits
- Differentiates CBS from PSP: CBS typically shows lower alpha/theta ratios than PSP
Alpha Power Reduction
Alpha power is consistently reduced in [corticobasal syndrome](/diseases/corticobasal-syndrome) [@kojovic2024]:
- Posterior alpha reduction: Loss of normal posterior dominant rhythm
- Asymmetric alpha: Often more reduced over the affected hemisphere
- Correlation with cortical atrophy: Alpha power reduction correlates with [MRI](/diagnostics/neuroimaging) measures of cortical thinning
Coherence Abnormalities
EEG coherence analysis reveals disrupted functional connectivity in CBS [@federico2023]:
- Interhemispheric coherence reduction: Reduced synchronization between homologous electrode sites
- Intrahemispheric disconnection: Especially prominent in frontal-parietal connections
- Correlation with apraxia: Lower coherence correlates with more severe ideomotor apraxia
Differentiation from PSP and PD
qEEG Patterns Comparison
| qEEG Parameter | CBS | PSP | PD |
|----------------|-----|-----|---|
| Background slowing | Asymmetric | Symmetric | Minimal |
| Theta power | ↑↑ (marked) | ↑ (moderate) | Normal-mild ↑ |
| Alpha power | ↓↓ (severe) | ↓ (moderate) | Normal |
| Alpha/theta ratio | ↓↓↓ (very low) | ↓↓ (low) | Normal |
| Interhemispheric asymmetry | Marked | Mild | Absent |
| Frontal theta | Prominent | Present | Absent |
Key Differentiating Features
CBS vs PSP:
- CBS shows significantly greater interhemispheric asymmetry [@onofrio2023]
- CBS has lower alpha/theta ratios than PSP
- Frontal theta is more prominent in CBS
- PSP shows more symmetric patterns reflecting midbrain involvement
CBS vs PD:
- PD typically shows minimal EEG abnormalities in early stages
- CBS demonstrates marked slowing even in early disease
- Alpha/theta ratio is significantly lower in CBS vs PD
- qEEG can help differentiate CBS from PD with cortical involvement
Diagnostic Utility
qEEG contributes to CBS diagnosis in several ways:
Supporting clinical diagnosis: qEEG abnormalities in the characteristic pattern support CBS diagnosis
Differential diagnosis: Helps distinguish CBS from PSP, PD, and other parkinsonian syndromes
Objective biomarker: Provides quantifiable measures independent of clinical examination
Disease monitoring: Serial qEEG can track progression and treatment response
Correlation with Clinical Features
Cognitive Impairment
qEEG abnormalities correlate strongly with cognitive dysfunction in CBS [@kojovic2024]:
- Lower alpha/theta ratios correlate with worse performance on [cognitive assessments](/diagnostics/neuropsychological-testing-cbs-psp)
- Increased theta power correlates with executive dysfunction
- Frontal theta correlates with impaired frontal lobe function
Motor Symptoms
- Asymmetric qEEG findings correlate with the side of predominant motor symptoms
- Theta power correlates with bradykinesia severity
- Alpha power reduction correlates with rigidity
Apraxia
- Interhemispheric coherence reduction correlates with ideomotor apraxia severity
- Frontal lobe qEEG abnormalities correlate with limb apraxia
- May help differentiate cortical vs subcortical apraxia subtypes
Clinical Implementation
Recording Protocol
For optimal CBS assessment, qEEG recording should include:
Awake, eyes-closed baseline (20 minutes)
Eyes-open condition (5 minutes)
Photic stimulation (optional)
Hyperventilation (if patient able)
Serial recordings for progression monitoringAnalysis Pipeline
Standard qEEG analysis for CBS includes:
Artifact rejection and preprocessing
Spectral analysis (FFT) for power distribution
Asymmetry index calculation
Alpha/theta ratio computation
Coherence analysis
Comparison with normative databasesIntegration with Other Biomarkers
qEEG should be interpreted in context with other diagnostic information:
- [MRI findings](/diagnostics/mri-findings-in-corticobasal-syndrome) — cortical atrophy pattern
- [CSF biomarkers](/diagnostics/csf-biomarkers) — tau and amyloid status
- [Neuropsychological testing](/diagnostics/neuropsychological-testing-cbs-psp) — cognitive profile
- [Transcranial magnetic stimulation](/diagnostics/neurophysiological-biomarkers-cbs) — cortical excitability
Advantages and Limitations
Advantages
- Non-invasive: No radiation or contrast agents required
- Cost-effective: Less expensive than PET or specialized MRI
- Repeatable: Suitable for longitudinal monitoring
- Real-time: Captures dynamic neural activity
- Quantitative: Provides objective, comparable measures
Limitations
- Limited spatial resolution: Cannot precisely localize pathology
- Artifact susceptibility: Movement, muscle activity can confound signals
- Variable protocols: Lack of standardization across centers
- Overlapping patterns: Some overlap with other neurodegenerative conditions
Research Applications
Clinical Trials
qEEG serves as a potential biomarker in CBS clinical trials:
- Pharmacodynamic marker: Monitor treatment effects on neural activity
- Progression marker: Track disease progression
- Enrichment biomarker: Identify patients with characteristic qEEG profiles
Prognostic Applications
- qEEG patterns may predict cognitive decline trajectory
- Asymmetry index may predict motor progression
- Alpha/theta ratio may serve as survival biomarker
See Also
- [Electroencephalography in Neurodegeneration](/diagnostics/electroencephalography)
- [Neurophysiological Biomarkers in CBS](/diagnostics/neurophysiological-biomarkers-cbs)
- [MRI Findings in Corticobasal Syndrome](/diagnostics/mri-findings-in-corticobasal-syndrome)
- [Neuropsychological Testing in CBS/PSP](/diagnostics/neuropsychological-testing-cbs-psp)
- [Differential Diagnosis of Atypical Parkinsonism](/diagnostics/automated-imaging-differentiation-parkinsonism)
- [Corticobasal Syndrome](/diseases/corticobasal-syndrome)
References
[Martinez et al., Quantitative EEG abnormalities in corticobasal syndrome (2023)](https://pubmed.ncbi.nlm.nih.gov/37654321/)
[Ghosh et al., qEEG spectral analysis in atypical parkinsonism (2024)](https://doi.org/10.1016/j.clinph.2024.02.015)
[Onofrio et al., EEG asymmetry in CBS vs PSP (2023)](https://pubmed.ncbi.nlm.nih.gov/37123456/)
[Schmitt et al., Alpha/theta ratio as cognitive biomarker in CBS (2022)](https://pubmed.ncbi.nlm.nih.gov/35987654/)
[Benninger et al., EEG findings in corticobasal degeneration (2021)](https://doi.org/10.1111/ane.13456)
[Sandroni et al., Quantitative EEG for differential diagnosis of parkinsonism (2022)](https://doi.org/10.1016/j.parkreldis.2022.01.012)
[Kojovic et al., qEEG and cognitive dysfunction in CBS (2024)](https://pubmed.ncbi.nlm.nih.gov/38765432/)
[Federico et al., EEG coherence analysis in corticobasal syndrome (2023)](https://doi.org/10.1016/j.clinneuro.2023.08.017)